EMCORE CORP (EMKR)

US2908464017 - Common Stock

2.09  +0.09 (+4.5%)

Fundamental Rating

2

EMKR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 51 industry peers in the Communications Equipment industry. EMKR may be in some trouble as it scores bad on both profitability and health. EMKR has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year EMKR has reported negative net income.
EMKR had a negative operating cash flow in the past year.
In the past 5 years EMKR reported 4 times negative net income.
In multiple years EMKR reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -64.29%, EMKR is not doing good in the industry: 96.08% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -133.38%, EMKR is doing worse than 82.35% of the companies in the same industry.
Industry RankSector Rank
ROA -64.29%
ROE -133.38%
ROIC N/A
ROA(3y)-17.02%
ROA(5y)-17.89%
ROE(3y)-31.94%
ROE(5y)-30.43%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 27.48%, EMKR is doing worse than 80.39% of the companies in the same industry.
EMKR's Gross Margin has improved in the last couple of years.
EMKR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.51%
GM growth 5Y2.09%

3

2. Health

2.1 Basic Checks

EMKR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EMKR has been increased compared to 1 year ago.
EMKR has more shares outstanding than it did 5 years ago.
EMKR has a worse debt/assets ratio than last year.

2.2 Solvency

EMKR has an Altman-Z score of -8.17. This is a bad value and indicates that EMKR is not financially healthy and even has some risk of bankruptcy.
EMKR has a Altman-Z score of -8.17. This is amonst the worse of the industry: EMKR underperforms 80.39% of its industry peers.
EMKR has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
EMKR's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. EMKR outperforms 64.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -8.17
ROIC/WACCN/A
WACC8.04%

2.3 Liquidity

EMKR has a Current Ratio of 2.88. This indicates that EMKR is financially healthy and has no problem in meeting its short term obligations.
EMKR has a Current ratio of 2.88. This is in the better half of the industry: EMKR outperforms 64.71% of its industry peers.
EMKR has a Quick Ratio of 1.64. This is a normal value and indicates that EMKR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.64, EMKR is doing good in the industry, outperforming 60.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 1.64

3

3. Growth

3.1 Past

EMKR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.73%, which is quite impressive.
EMKR shows a strong growth in Revenue. In the last year, the Revenue has grown by 414.48%.
EMKR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.68% yearly.
EPS 1Y (TTM)85.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.31%
Revenue 1Y (TTM)414.48%
Revenue growth 3Y-3.91%
Revenue growth 5Y2.68%
Sales Q2Q%-23.46%

3.2 Future

Based on estimates for the next years, EMKR will show a very strong growth in Earnings Per Share. The EPS will grow by 38.95% on average per year.
Based on estimates for the next years, EMKR will show a decrease in Revenue. The Revenue will decrease by -6.42% on average per year.
EPS Next Y84.79%
EPS Next 2Y38.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-18.21%
Revenue Next 2Y-6.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

EMKR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EMKR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

EMKR's earnings are expected to grow with 38.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.95%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EMKR!.
Industry RankSector Rank
Dividend Yield N/A

EMCORE CORP

NASDAQ:EMKR (11/4/2024, 8:05:16 PM)

2.09

+0.09 (+4.5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.96M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.29%
ROE -133.38%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 27.48%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.88
Quick Ratio 1.64
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)85.73%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y84.79%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)414.48%
Revenue growth 3Y-3.91%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y